About NeuroStar
NeuroStar is a publicly listed company based in Malvern (United States) founded in 2003. Non-invasive TMS therapy is provided for major depressive disorder treatment. NeuroStar has raised $118.69 million across 7 funding rounds from investors including Pfizer, General Electric and New Leaf Venture Partners. The company has 716 employees. Its website neurostar.com draws about 24 thousand monthly visits. NeuroStar offers products and services including NeuroStar TMS System and NeuroStar Advanced Therapy. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is NEURONETICS, INC. Its competitors include Soterix Medical, Neuroprex and TMSWorkbook; 1 of its 3 listed competitors has raised funding.
Company details
NeuroStar was founded in 2003 and is headquartered in Malvern, United States. Operations center on the development of non-drug, non-invasive devices utilizing MRI-strength pulsed magnetic fields for neurorehabilitation. Therapeutic applications target central nervous system disorders, with TMS Therapy serving as an FDA-cleared option for adults with major depressive disorder who have not responded adequately to prior antidepressant treatments.
- Annual Revenue$149.16 M (USD)99.17as on Dec 31, 2025
- Net Profit-$39 M (USD)10.78as on Dec 31, 2025
- EBITDA-$27.97 M (USD)13.91as on Dec 31, 2025
- Total Equity Funding$118.69M (USD)
in 7 rounds
- InvestorsPfizer
& 12 more
- Employee Count716
Products & Services of NeuroStar
NeuroStar offers a comprehensive portfolio of products and services, including NeuroStar TMS System and NeuroStar Advanced Therapy.
Non-invasive treatment using magnetic pulses for depression relief.
Adjunct treatment for OCD and anxious depression in patients.
Funding Insights of NeuroStar
NeuroStar has successfully raised a total of $118.69M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $118.69M
- Total Rounds 7
- First Round $30M
(Aug 2009)
- Investors Count 13
All 7 funding rounds of NeuroStar with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | Debt – Conventional | – | – | ||
| Jun 2017 | $15M | Series G | – | Ascension Ventures | |
| May 2015 | $34.34M | Series C | – | – | – |
| Nov 2014 | $9.07M | Series C | – | – | – |
| Dec 2012 | $271,500 | Series C | – | – | – |
| May 2011 | $30M | Series C | – | – | – |
| Aug 2009 | $30M | Series C | – | – | – |
13 investors in total: 13 institutional.
Investors in NeuroStar
NeuroStar has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, General Electric and New Leaf Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private debt investments are managed for middle-market companies. | 2006 | slrinvestmentcorp.com | New York, United States | |
Strategic investments in healthcare technologies and data innovations. | ascensionventures.org | |||
Early-stage US healthcare investments are made by Accuitive Medical Ventures. | amvpartners.com | Duluth, United States | ||
Early-stage investing in IT and healthcare ventures. | interwest.com | |||
Investments in private tech ecosystem are made by Industry Ventures. | industryventures.com | San Francisco, United States | ||
| patriciaindustries.com | ||||
Limited information is provided about KBL Healthcare Ventures. | kblhealthcare.com | |||
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
Early stage VC firm investing in the US | onset.com | Menlo Park, United States | ||
US focused venture capital firm | polarispartners.com | Boston, United States |
Investor details for NeuroStar
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NeuroStar
50 people are tracked at NeuroStar (23 in leadership, 5 in board & advisors, 22 in team); the tracked headcount is 716.
| Name | Role | Group |
|---|---|---|
Keith J. Sullivan | President & CEO | Leadership |
Todd Cushman | VP, Business Development | Leadership |
Jeffrey Jones | Sr Vice President, Chief Of Operations | Leadership |
Sara Grubbs | VP, Sales | Leadership |
Nusrat Samjani | Associate Director, Assistant Controller | Leadership |
Steven Pfanstiel | Executive Vice President, Chief Financial Officer And Treasurer | Leadership |
Cory Anderson | VP, Clinical Affairs & Interim VP, R&D | Leadership |
Lisa Metzner-Rosas | SVP, Chief Marketing Officer | Leadership |
Steve Furlong | VP & CFO | Leadership |
Andrew Macan | SVP, General Counsel, Chief Compliance Officer & Corporate Secretary | Leadership |
Anthony Pui | VP, International Commercial Development | Leadership |
Madeleine Sullivan | Director Of Sales Training & Customer Education | Leadership |
Christine Nugent | Director Corporate Finance | Leadership |
Jenn Lazar | Associate Vice President Human Resources | Leadership |
Daniel Pont | Human Resources Director | Leadership |
Alexandra Williamson | Associate Vice President Of Quality Assurance | Leadership |
Victoria Stezzi | Director Of Customer Operations & Reimbursement Support | Leadership |
Catherine Walts | Associate Director, Digital Marketing | Leadership |
Trevor Seck | Senior Director Of Marketing | Leadership |
Wendy Suljak | Vice President, Consumer & Practice Marketing | Leadership |
30 more people are available in the full profile.
Complete people profiles for NeuroStar
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of NeuroStar
NeuroStar is a publicly listed company on the NASDAQ with ticker symbol STIM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Jun 2018
- Listed onNASDAQ: STIM
- Listed entityNeuronetics, Inc.
- Exchange sectorHealth technology
- ISINUS64131A1051
- Share price$1.99 (-6.57% on the day) · 2026-10-13
- Market capitalisation$151.6M
- EPS (diluted, trailing year)$-0.44
- Volume (last session)547,945
Financials of NeuroStar
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $149.2M | -$39.0M | -$28.0M |
| 2024 | $74.9M | -$43.7M | -$32.5M |
| 2023 | $71.3M | -$30.2M | -$28.6M |
| 2022 | $65.2M | -$37.2M | -$32.4M |
| 2021 | $55.3M | -$31.2M | -$24.9M |
Detailed financial statements for NeuroStar
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of NeuroStar
4 dated milestones of NeuroStar across 17 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroStar is founded.
- Funding First funding round of $30.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt – Conventional,.
Competitors of NeuroStar
NeuroStar has 3 listed competitors in our database, 1 of them funded. They include Soterix Medical, Neuroprex and TMSWorkbook.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| soterixmedical.com | 2008 | New York, United States | Non-invasive neuromodulation devices for mood disorders are manufactured. | |||
| neuroprexinc.com | 2012 | Santa Clara, United States | $50,000 | Wearable devices are developed to modulate tissues for neurological diseases. | ||
| tmsworkbook.com | 2018 | Nashville, United States | Digital platform for TMS therapy modules and patient assessments. |
Detailed competitors of NeuroStar
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NeuroStar
The website of NeuroStar (neurostar.com) receives about 23.6K visits a month and ranks #1,074,280 among all websites worldwide, #1,966 in Mental Health.
- Monthly visits23.6K
▼ 13.5% vs previous month
- Unique visitors10.7K
per month
- Global rank#1,074,280
among all websites
- Category rank#1,966
Health · Mental Health
- Bounce rate51%
- Pages per visit2.3
- Average visit2 min 09 sec
- DevicesDesktop 16% · Mobile 84%
Websites whose visitors overlap most with NeuroStar. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
tmsneuro.com | tmsneuro.com | 100% | – | ||
| greenbrooktms.com | 90% | 40.5K | View details | ||
| getgoally.com | 83% | 74.6K | #596,716 | View details | |
| brainbalancecenters.com | 83% | 70.9K | #409,288 | View details | |
mindermemory.com | mindermemory.com | 82% | #1,290,640 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 23 similar websites and full traffic analytics for NeuroStar
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 23 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as NeuroStar (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurostar
Complete news archive for NeuroStar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroStar
NeuroStar was founded in 2003 and raised its 1st funding round 6 years after it was founded.
NeuroStar is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
NeuroStar is a funded company, having raised a total of $118.69M across 7 funding rounds to date. The company's 1st funding round was a Series C of $30M, raised on Aug 2009.
NeuroStar has 716 employees.
Annual revenue of NeuroStar is $149.16M as on Dec 31, 2025.
NeuroStar was founded in 2003 and is headquartered in Malvern, United States. Operations center on the development of non-drug, non-invasive devices utilizing MRI-strength pulsed magnetic fields for neurorehabilitation. Therapeutic applications target central nervous system disorders, with TMS Therapy serving as an FDA-cleared option for adults with major depressive disorder who have not responded adequately to prior antidepressant treatments.
NeuroStar's top competitors include Neuroprex, Soterix Medical and TMSWorkbook.
NeuroStar offers NeuroStar TMS System and NeuroStar Advanced Therapy.
Yes, NeuroStar is publicly traded on NASDAQ under the ticker symbol STIM.
NeuroStar has 13 investors. Key investors include Pfizer, General Electric, New Leaf Venture Partners, SLR Investment, and Ascension Ventures.
NeuroStar operates through Neuronetics, Inc..